Follow-The-Filings

Security

Coya Therapeutics Inc. · COMMON STOCK

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 1 exit max 0.5% (David Einhorn - Greenligh...)

owners 6
max % 0.5%
tracked value $16M
qoq A 4 R 2 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
David Einhorn - Greenlight Capital Inc. 2023 Q4 stale 0.5% Add +0.36 pp 1,274,026 $9M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 899,140 $5M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 225,792 $890 hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 103,964 $410 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 37,681 $148 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 16,859 $66 hist
Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 20,837 $121 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6M $3.55M $7.95M
Gross profit
Gross margin
Net income -$7.99M -$14.88M -$21.23M
Net margin * -133.1% -418.7% -267.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $41.2M $44.31M $49.94M
Total non-current assets * $65,949 $38,588 $11,227
Total assets $41.26M $44.35M $49.95M
Total current liabilities $5.05M $3.82M $5.87M
Total non-current liabilities * $574,685 $945,447 $1.05M
Total equity $35.64M $39.58M $43.03M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$11.19M -$10.29M -$10.74M
Cash from investing -$543,186 -$25,000 -$1.16M
Cash from financing $38.43M $16.03M $20.39M
Net change in cash * $26.69M $5.71M $8.48M

ownership over time

filing count by report period · click a bar for that quarter’s holders